Baxter International | BAX - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Abbott USD 4.27B 669M 2026-09
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 82.88M 319K 2026-09
Baxter International USD 730M 5M 2026-09
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Boston Scientific USD 1.68B 120M 2026-09
Cooper Companies USD 401.3M 274.9M 2026-06
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Fresenius EUR 760M 17M 2026-06
Globus Medical USD 286.82M 10.95M 2026-06
Halozyme Therapeutics USD 57M 10.71M 2026-06
ICU Medical USD 151.92M 2.64M 2026-06
Inogen USD 43.77M 510K 2024-06
Insulet USD 350.7M 5.9M 2026-09
Integra LifeSciences USD 161.02M 5.2M 2026-09
Intuitive Surgical USD 1.08B 465.5M 2026-09
J&J USD 6.25B 168M 2026-09
Laboratory Of America USD 611.4M 34.2M 2026-09
Medtronic 3.2B 141M 2026-06
Merit Medical Systems USD 129.23M 18.76M 2026-06
Quest Diagnostics USD 523M 6M 2026-09
Smith & Nephew USD 1.45B 29M 2026-06
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 111.64M 3.45M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
Terumo JPY 109.7B 5.11B 2026-06
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06